Skip to content

STERIS STE Investing Cash Flow

Investing Cash Flow at other companies

Baxter International logo
Baxter InternationalBAX
-$133M-104%
Ecolab logo
EcolabECL
-$355.5M-58.7%
3M logo
3MMMM
-$483M-790%
Stryker logo
StrykerSYK
-$185M+95.5%
Mesa Laboratories logo
Mesa LaboratoriesMLAB
-$417K+58.6%
Boston Scientific logo
Boston ScientificBSX
-$591M-18.2%

Other financials

Income statement

See full
Revenue$1.6B+7.3%
Gross profit$697.2M+8.8%
Operating income$316.8M+46.6%
Net income$220.2M+51.2%
EPS (diluted)$2.24+52.4%

Balance sheet

See full
Cash & equivalents$439.6M+156%
Total debt$2.1B-10.3%
Total equity$7.2B+8.8%
Total assets$10.7B+5.8%

Cash flow

See full
Operating cash flow$335.4M+28.6%
CapEx$90.2M+27.2%
Free cash flow$245.2M+29.1%

Valuation

See full
Market cap$20.64B-7.5%
Enterprise value$22.28B-7.0%
P/E26.4×-8.1×
P/S3.5×-0.5×

Profitability

See full
Gross margin44.2%+0.2pp
Operating margin18.6%+2.7pp
Net margin13.2%+1.9pp
FCF margin16.4%+2.1pp

Returns & leverage

See full
Return on equity11.3%+1.8pp
Debt / equity0.3×-0.1×
Current ratio2.1×+0.1×

Where this comes from

Reported directly by STERIS in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.

The official record: STERIS’s 10-K, filed May 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about STERIS's investing cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is STERIS's investing cash flow?
STERIS (STE) reported investing cash flow of -$217.2M in Q1 2026.
What is the long-term trend for STERIS's investing cash flow?
Over 2 years (2023 to 2026), STERIS's investing cash flow has grown at a 15.6% compound annual growth rate (CAGR), from -$383.33M to -$512.5M.
What does investing cash flow mean?
Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.